Senior Director, Customer Engagement Strategy & Operations Revolution Medicines IncSenior Director, Customer Engagement Strategy & OperationsRedwood City, CA$244,000–$305,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Connect commercial and technical teams by defining solutions or journeys that include generative or agentic AI solutions, intended outcomes, data requirements, success measures and leading by example to move these solutions from ideation to pilot to production and scale.
Associate Director, Global Commercial & Medical Data Products Revolution Medicines IncAssociate Director, Global Commercial & Medical Data ProductsRedwood City, CA$186,000–$233,000 / yearRevolution Medicines Information Sciences & Digital Innovation (ISDI) is seeking an Associate Director, Global Commercial & Medical Data Products to lead the strategy, evolution, and delivery of enterprise Commercial and Medical data products supporting international markets, with an initial focus on Europe and Japan. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Director, Stanford Language Center Stanford UniversityDirector, Stanford Language CenterStanford, CA$149,247–$255,852 / yearThe pay offered to the selected candidate will be determined based on factors including (but not limited to) the experience and qualifications of the selected candidate including years since terminal degree, training, and field or discipline; departmental budget availability; and internal equity. Position Overview: Stanford University invites applications for the position of Director of the Stanford Language Center (SLC), a faculty position as Associate or Full Professor (Teaching) within one of the language and literature departments in the School of Humanities & Sciences.
Associate Director, Global Field Solutions Revolution Medicines IncAssociate Director, Global Field SolutionsRedwood City, CA$186,000–$233,000 / yearThe Opportunity: Revolution Medicines Information Sciences and Digital Innovation (ISDI) team is seeking an Associate Director, Global Field Solutions to lead the successful implementation of Commercial and Medical Go-To-Market technology solutions for field teams across new global regions, with an initial focus on Europe and Japan/Asia-Pacific. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Associate Director, Revenue Accounting and Finance Revolution Medicines IncAssociate Director, Revenue Accounting and FinanceRedwood City, CA$186,000–$233,000 / yearPrepare and analyze monthly product revenue and gross-to-net close activities, including the calculation, recording, and monitoring of gross-to-net accruals and related reserve balances for prompt pay discounts, copay and patient assistance programs, returns, Medicaid, Medicare Part D, 340B, VA/DoD, and other forms of variable consideration. Manage the day-to-day partnership with the external government pricing consultant, including coordinating required data submissions, reviewing government pricing calculations and related outputs, and supporting accuracy and compliance across government channels, including Medicaid, Medicare Part D, 340B, and VA/FSS programs.
Senior Director, Global SOX Revolution Medicines IncSenior Director, Global SOXRedwood City, CAThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. This role has enterprise-wide governance responsibility for ICFR, ITGCs, ITACs, automated controls, key reports, and controls supporting evolving business processes, systems, commercial readiness, and global expansion.
Director, Transactions Lakefront Biotherapeutics NVDirector, TransactionsSan Francisco, CA$230,000–$250,000 / yearLakefront Biotherapeutics is a global biotech with offices in Belgium, Chicago and San Francisco, focused on building a differentiated immunology and inflammation pipeline to address serious diseases with high unmet medical need. As Director Transactions, you will play a key role in supporting the Chief Business Officer (CBO) and Vice President of Transactions in the execution of business development activities.
Director of Reimbursement NeuroPace IncDirector of ReimbursementMountain View, CA$172,000–$228,000 / yearProven success in coverage expansion working directly with private and public payers on coverage for new product launches, label expansions, or newly approved clinical indications. Based in Mountain View, CA., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures.
Director, Global CMC Regulatory Revolution Medicines IncDirector, Global CMC RegulatoryRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner with Regulatory Affairs, technical SMEs, and CROs to ensure alignment of global submission strategies while addressing region-specific CMC requirements and serve as the CMC regulatory representative on global commercial teams to provide guidance that enables efficient global execution.
Associate Director, Program Management Revolution Medicines IncAssociate Director, Program ManagementRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Identify critical path activities, resource constraints, risks, and conflicts that could impact the timelines or budget; work with subject matter experts to construct appropriate mitigation plans.
Associate Director, Analytical Development & QC Revolution Medicines IncAssociate Director, Analytical Development & QCRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Solid understanding of relevant global and regional regulatory guidelines (FDA, EU, and ICH, etc.) as applicable to QbD, commercial process validation, commercial product launch, commercial manufacture sampling and testing, and post-approval quality control requirements.
Director, Medical Communications Revolution Medicines IncDirector, Medical CommunicationsRedwood City, CA$211,000–$264,000 / yearThe Opportunity: As a new member of the Revolution Medicines team, the Director, Medical Communications will lead the development and execution of a comprehensive medical communications strategy, ensuring alignment across internal and external stakeholders for select assets across pipeline, with focus on pancreatic cancer, NSCLC, colorectal cancer, and other solid tumors. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS.
Director of Business Development, Pharma Partnerships Vivo HealthStaffDirector of Business Development, Pharma PartnershipsBerkeley, CAFull timeA demonstrated record of personally sourcing, negotiating, and closing complex enterprise contracts.• Experience navigating pharmaceutical procurement, legal, security, compliance, and multi-stakeholder buying processes.• Strong executive communication, consultative selling, and negotiation skills.• Comfortable operating independently in an early-stage company without an established sales playbook.• Experience growing existing accounts in addition to winning new business. Partner with Oaklet's product, clinical, and technical teams to design programs around customer needs.• Own executive relationships after closing, identifying opportunities for renewal and account expansion.• Help shape Oaklet's pharmaceutical positioning, pricing, sales process, and go-to-market strategy.• Maintain disciplined pipeline management and revenue forecasting.
Director, Nonclinical Toxicology Operations Nurix Therapeutics IncDirector, Nonclinical Toxicology OperationsBrisbane, CA$220,700–$252,667 / yearThe first is operational support to the nonclinical Safety and Toxicology function - helping study directors and toxicology leads scope and design studies, selecting and managing CROs, negotiating and administering contracts, and keeping study execution on schedule and on budget. The ideal candidate will be adept at partnering closely with subject matter experts, preclinical Project Leads, clinical Asset Team Leaders, and the SVP of Preclinical Toxicology who will provide oversight and scientific direction.
Executive Director, Early Clinical Development Revolution MedicinesExecutive Director, Early Clinical DevelopmentRedwood City, California$265,000–$331,000 / yearHas demonstrated collaborate behaviors on enterprise-level strategic initiatives with a variety of internal and external partners and stakeholders - including clinical investigators/clinicians, scientists and key opinion leaders (KOLs), as well as internal groups, including other groups in development, research, business development, commercial, legal, etc. In this critical role, you will be responsible for developing the strategic plans and ensuring efficient operational execution of the molecule(s)’ clinical development program in one or more disease indications, from early-stage studies to regulatory submissions and potential commercialization.
Senior Director, Clinical Development Revolution Medicines IncSenior Director, Clinical DevelopmentRedwood City, CA$244,000–$305,000 / yearHas demonstrated collaborate behaviors on enterprise-level strategic initiatives with a variety of internal and external partners and stakeholders - including clinical investigators/clinicians, scientists and key opinion leaders (KOLs), as well as internal groups, including other groups in development, research, business development, commercial, legal, etc. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Director - Quality Management & Regulatory Affairs Stanford Health CareDirector - Quality Management & Regulatory AffairsPalo Alto, California$89.01–$117.94 / hourReporting to the Executive Director for Quality, Patient Safety & Infection Prevention, the Director collaborates with cross-functional leaders and teams within Stanford Health Care and Stanford School of Medicine to develop and implement the quality assessment and performance improvement plan (QAPI).The key areas of responsibility include development and implementation of the tactics and communication plans which ensure that the organization is continually prepared for reliable care in accordance of accreditation, federal and state regulatory requirements. In this highly visible role, you'll partner with executive and clinical leaders, mentor high-performing teams, and drive the strategies that strengthen regulatory excellence, patient safety, and continuous readiness.
Senior Director Supply Chain Support Services - Fixed Term Stanford Health CareSenior Director Supply Chain Support Services - Fixed TermHayward, California$94.35–$125.03 / hourA Brief Overview Reporting directly to the Chief Supply Chain Officer, the Senior Director is responsible for leading functions across Supply Chain operations, including the Resiliency Program Office and supply reliability, the Supply Chain support center, mail services, and warehousing. This is a multi-faceted managerial job class with substantial responsibility for the exercise of independent judgment in interviewing, selecting, and training subordinates, assigning work, developing work procedures, establishing work schedules, monitoring and evaluating the work performed by subordinates, and disciplining subordinates.
Executive Director Integral Senior Living LLCExecutive DirectorHayward, CA$2,022–$2,026Integral Senior Living (ISL) proudly manages care and lifestyle-focused Independent Living, Assisted Living and Memory Care communities across California and surrounding areas serving thousands of residents and families throughout the region. Demonstrates the ability to identify and build relationships within the local area that drives businesses into the community, as well as effectively price the product, thereby maximizing top-line revenue growth and achieves appropriate market position.
Life Sciences MedTech R&D, Management Consulting Principal Director Accenture PlcLife Sciences MedTech R&D, Management Consulting Principal DirectorMountain View, CAAccenture is a leading solutions and services company that helps the world's leading enterprises reinvent by building their digital core and unleashing the power of AI to create value at speed across the enterprise, bringing together the talent of our approximately 786,000 people, our proprietary assets and platforms, and deep ecosystem relationships. From strategy through execution, we help clients navigate regulatory complexity, accelerate product development timelines, and build the AI-enabled operating models that will define the next era of medical technology.